Utilization of Aloe Compounds in Combatting Viral Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Espano, Erica | - |
dc.contributor.author | Kim, Jiyeon | - |
dc.contributor.author | Kim, Jeong-Ki | - |
dc.date.accessioned | 2022-06-10T09:40:39Z | - |
dc.date.available | 2022-06-10T09:40:39Z | - |
dc.date.created | 2022-06-10 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/141837 | - |
dc.description.abstract | Plants contain underutilized resources of compounds that can be employed to combat viral diseases. Aloe vera (L.) Burm. f. (syn. Aloe barbadensis Mill.) has a long history of use in traditional medicine, and A. vera extracts have been reported to possess a huge breadth of pharmacological activities. Here, we discuss the potential of A. vera compounds as antivirals and immunomodulators for the treatment of viral diseases. In particular, we highlight the use of aloe emodin and acemannan as lead compounds that should be considered for further development in the management and prevention of viral diseases. Given the immunomodulatory capacity of A. vera compounds, especially those found in Aloe gel, we also put forward the idea that these compounds should be considered as adjuvants for viral vaccines. Lastly, we present some of the current limitations to the clinical applications of compounds from Aloe, especially from A. vera. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | MACROPHAGE CELL-LINE | - |
dc.subject | ANTIVIRAL ACTIVITY | - |
dc.subject | VERA GEL | - |
dc.subject | EMODIN | - |
dc.subject | INFLUENZA | - |
dc.subject | ACEMANNAN | - |
dc.subject | VIRUS | - |
dc.subject | ANTHRAQUINONES | - |
dc.subject | EXTRACT | - |
dc.subject | EXPRESSION | - |
dc.title | Utilization of Aloe Compounds in Combatting Viral Diseases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jeong-Ki | - |
dc.identifier.doi | 10.3390/ph15050599 | - |
dc.identifier.scopusid | 2-s2.0-85130594573 | - |
dc.identifier.wosid | 000801400400001 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICALS, v.15, no.5 | - |
dc.relation.isPartOf | PHARMACEUTICALS | - |
dc.citation.title | PHARMACEUTICALS | - |
dc.citation.volume | 15 | - |
dc.citation.number | 5 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MACROPHAGE CELL-LINE | - |
dc.subject.keywordPlus | ANTIVIRAL ACTIVITY | - |
dc.subject.keywordPlus | VERA GEL | - |
dc.subject.keywordPlus | EMODIN | - |
dc.subject.keywordPlus | INFLUENZA | - |
dc.subject.keywordPlus | ACEMANNAN | - |
dc.subject.keywordPlus | VIRUS | - |
dc.subject.keywordPlus | ANTHRAQUINONES | - |
dc.subject.keywordPlus | EXTRACT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | Aloe barbadensis | - |
dc.subject.keywordAuthor | Aloe vera | - |
dc.subject.keywordAuthor | antivirals | - |
dc.subject.keywordAuthor | adjuvants | - |
dc.subject.keywordAuthor | immunomodulator | - |
dc.subject.keywordAuthor | phytochemicals | - |
dc.subject.keywordAuthor | aloe emodin | - |
dc.subject.keywordAuthor | aloin | - |
dc.subject.keywordAuthor | acemannan | - |
dc.subject.keywordAuthor | natural products | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.